NCT05848401 is a NA clinical trial of Biosound Therapy System in Long COVID, sponsored by Anxiety Relief Center.

Who is sponsoring NCT05848401?

NCT05848401 is sponsored by Anxiety Relief Center.

What drugs are being tested in NCT05848401?

Interventions in NCT05848401: Biosound Therapy System.

What condition does NCT05848401 study?

NCT05848401 studies Long COVID.

Is NCT05848401 still recruiting?

NCT05848401 is currently completed. Last updated 8 May 2023.

Last reviewed 2023-05-08 · How we verify

NCT05848401

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Biosound Therapy as a Treatment for Long COVID Patients

Completed NA Last updated 8 May 2023

What this trial tests

NA trial testing Biosound Therapy System in Long COVID in 13 participants. Completed in 19 January 2022.

Timeline

29 April 2021

Primary endpoint
5 January 2022

19 January 2022

Quick facts

Lead sponsor	Anxiety Relief Center
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	single group
Masking	none
Primary purpose	treatment
Enrollment	13
Start date	29 April 2021
Primary completion	5 January 2022
Estimated completion	19 January 2022
Sites	1 location across United States

Drugs / interventions tested

Biosound Therapy System

Conditions studied

Long COVID — all drugs for Long COVID →

Sponsor

Anxiety Relief Center

Who can join

Adults 20 to 65, any sex, with Long COVID. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study aimed to explore the impact of the Biosound Therapy Systerm on long COVID symptoms while determining feasibility of a future full-scale Randomized Controlled Trial. It was hypothesized that Biosound treatment would significantly improve long COVID. The goal of this clinical trial is to learn about Biosound Therapy System's impact on long COVID symptoms. The main questions it aims to answer are: * How does Biosound Therapy impact long COVID symptoms? * Is the protocol for this trial feasible for a future full-scale Randomized Controlled Trial? Participants with long COVID symptoms will be assigned to a control group and treatment group. The control group will receive no treatment. The treatment group will have 8 sessions of Biosound Therapy. Researchers will compare the treatment and control group to see if there's a difference in long COVID symptoms.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Long COVID

Currently open trials in the same condition.

NCT05931497 — Sauna for Long Covid · NA · recruiting
NCT06452095 — Recovering From COVID-19 Lingering Symptoms Adaptive Integrative Medicine Trial - Effect of Hyperbaric Oxygen Therapy fo · NA · recruiting
NCT07316127 — Immunoadsorption in Autoimmune Long COVID · Phase 2 · recruiting
NCT07435805 — Long-Term Health Effects of Previous COVID-19 in Patients Undergoing Preoperative Anesthesia Evaluation · recruiting
NCT07278206 — Brain Stimulation in Long COVID · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05848401 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Anxiety Relief Center
Last refreshed: 8 May 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05848401.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing